Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

60-Hz light entrainment to unlock mental health conditions

Project description

60-Hz entrainment’s potential in anxiety disorders

Mental health issues represent an increasing societal burden. While psychiatric medications often show limited effectiveness, recent research has demonstrated that non-invasive light at 60 Hz can help remove the perineuronal net (PNN) in mice, enhancing cognitive performance. This discovery offers a promising avenue for mental health treatment. The ERC-funded SYNTROPIC project will assess the therapeutic potential of 60-Hz entrainment in a preclinical model of anxiety disorders and post-traumatic stress disorder (PTSD). The project aims to identify the optimal stage of fear memory formation for treatment, refine the duration and frequency of therapy, and establish physiological criteria for success. These findings will support prototype development and provide a therapeutic framework crucial for transitioning to clinical studies, ultimately paving the way for a spin-off company.

Objective

Mental health problems are a critical and ever-increasing burden to society. Psychiatric medications aim to adjust imbalances in synapse signaling, but often have only moderate-to-weak efficacy. Psychiatric medications aim to adjust imbalance in synapse signaling but often have only moderate-to-weak efficacy. The main challenge is that certain neuronal infrastructures for cognitive and emotional skills are secured with a rigid extracellular matrix known as the perineuronal net (PNN) that forms around neurons and locks the brain in a function state. Enzymatic interventions that can release the lock have been evaluated in mice, but they are not appropriate for translating into human therapeutics because they are invasive and prevent the reformation of PNN making the brain vulnerable. In the context of the ERC StG, we discovered that non-invasive external light entrainment at highly-selective 60-Hz enables microglia localized within the neuronal network to transiently remove PNN in a controlled and brain region-specific manner in both sexes with improved cognitive performances in mice. Thus, our discovery solves the urgent need for a targeted, non-invasive, non-pharmacological, therefore environmental-friendly therapeutic intervention. This ERC Proof-of-Concept will allow us to expand on our discovery and evaluate the therapeutic potential in a preclinical mouse model of anxiety disorder, post-traumatic stress disorder (PTSD). Our objectives are to identify at which stage of the fear memory formation 60-Hz entrainment shows the highest benefit, adjust treatment length and repetition frequency, and validate physiological parameters as a therapeutic success criterium. These insights will refine the first prototype development and set the therapeutic frame, which will both be critical to smoothen the transition into a clinical study post-ERC PoC, and will set the foundation for a spin-off company.

Fields of science (EuroSciVoc)

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC-POC - HORIZON ERC Proof of Concept Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2023-POC

See all projects funded under this call

Host institution

INSTITUTE OF SCIENCE AND TECHNOLOGY AUSTRIA
Net EU contribution
€ 150 000,00
Address
Am Campus 1
3400 Klosterneuburg
Austria
Region
Ostösterreich Niederösterreich Wiener Umland/Nordteil
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Beneficiaries (1)